Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1138-1139

  Moloney, F ^a,c,d   Vestergaard, M ^b,c,d   Radojkovic, B ^b,d   Damian, D ^a,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Dermatology ^*  (Australia)

^c Sydney Melanoma Unit   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Niacinamide; Precancers; Skin cancer; Ultraviolet immunosuppression

Indexed keywords

NICOTINAMIDE;

ACTINIC KERATOSIS; ADULT; AGED; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LETTER; MALE; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; NIACINAMIDE; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 77951222947     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09659.x     Document Type: Letter

References (10)

1. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol 2007 157 : 18 20. (Pubitemid 350179624)
2. Sivapirabu G, Yiasemides E, Halliday GM et al. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2009 161 : 1357 1364.
3. Moloney FJ, Comber H, O'Lorcain P et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006 154 : 498 504. (Pubitemid 43382659)
4. Magni G, Amici A, Emanuelli M et al. Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 2004 61 : 19 34.
5. Damian DL, Patterson CRS, Stapelberg M et al. Ultraviolet radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008 128 : 447 454.
6. Svobodova A, Zdarilova A, Maliskova J et al. Attenuation of UVA-induced damage to human keratinocytes by silymarin. J Dermatol Sci 2007 46 : 21 30. (Pubitemid 46366634)
7. Gensler HL. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr Cancer 1997 29 : 157 162.
8. Criscione VD, Weinstock MA, Naylor MF et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Cancer 2009 115 : 2523 2530.
9. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993 329 : 1147 1151. (Pubitemid 23295456)
10. Hiramoto K, Tanaka H, Yanagihara N et al. Effect of 17 beta-estradiol on immunosuppression induced by ultraviolet B irradiation. Arch Dermatol Res 2004 295 : 307 311. (Pubitemid 38314100)